Prenetics Global Limited (PRE)

4.3500 +0.1500 (+3.57%) At close: 12:40PM EST

Prenetics Global Limited

Unit 701-706, K11 Atelier King’s Road
728 King’s Road
Quarry Bay
Hong Kong
852 2210 9588
https://www.prenetics.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 400

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Sheng Wu Yeung	Co-Founder, Chairperson, CEO & CEO of Insighta	N/A	N/A	1979
Dr. Chi Hung Tzang Ph.D.	Co-Founder, Chief Scientific Officer & Member of Scientific Advisory Board	N/A	N/A	1975
Mr. Hoi Chun Lo	Chief Financial Officer	N/A	N/A	1985
Dr. Yung Ho Wong DPHIL	Chief Technology Officer	N/A	N/A	1982
Ms. Yvonne L. Wong	Chief Corporate Development Officer	N/A	N/A	N/A
Ms. Samantha Kwok	Vice President People & Culture	N/A	N/A	N/A
Dr. Senthil Sundaram M.D.	Chief Clinical Officer	N/A	N/A	1974
Mr. Avrom Boris Lasarow	Chief Executive Officer of EMEA	N/A	N/A	1977
Dr. Shih-Chang Ong M.D.	Chief Medical Officer & Member of Scientific Advisory Board	N/A	N/A	1978
Mr. Joel Neoh	Chief Consumer Officer & MD for CircleDNA	N/A	N/A	N/A

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Prenetics Global Limited operates as a diagnostics and genetic testing company in Hong Kong and the United Kingdom. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring device that offers COVID-19 testing solutions for professional use and home use. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; ACTOnco, a comprehensive test that helps clinicians choose the optimal treatment for all major solid tumors; ACTDrug+, a screening test that checks for 40 cancer genes to map drug options and provide treatment strategy options; ACTLung, a test focused on biomarkers associated with lung cancer for targeted therapy; ACTFusion, a test that decodes 13 fusion genes and more than 350 transcripts to map drug options; and ACTCerebra, a genomic profiling service for solid tumors. It also offers ACTMonitor, a test that analyzes 50 forms of circulating tumor DNA in the bloodstream; and ACT Risk, a screening of 67 cancer genes associated with 9 common hereditary cancers and 11 cancer syndromes. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Corporate Governance

Prenetics Global Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.